Page 5 - Serum Institute Of India

Serum CEO Adar Poonawalla urges Djokovic to get vaccinated against Covid

Serum Institute of India CEO Adar Poonawalla on Thursday urged Serbian tennis superstar Novak Djokovic to get vaccinated against Coronavirus.

Serum backed Mylab to make and sell Covid-19 vax, working on 2-3 platforms

Partners with Shilpa Medicare to manufacture vaccines, therapeutics

SII urges Mandaviya to reduce gap between 2nd, precaution dose to 3 months

Serum Institute has urged Union Health Minister Mansukh Mandaviya to consider reducing the gap between the second and the precaution dose of Covishield from current nine months to three

No full marketing authorisation yet for Covishield and Covaxin vaccines

Review process to continue, experts studying data submitted

What are the new Covid-19 vaccine platforms?

Rising cases of Covid-19 have unsettled the government. It recently approved two new vaccines. But, what is the difference between these vaccines? What platforms are used to develop them? Find out

Delta to Omicron: Looking back at Covid-19 pandemic's journey in 2021

With omicron presenting another challenge, the country is working to be better prepared this time around.

'Over 1 bn Covishield doses given in India, abroad testimony of its safety'

100 crore Covishield doses have been given in India and abroad which is a testimony of its safety and efficacy, Serum Institute has informed the DCGI

Serum Institute applies for full marketing authorisation of Covishield

Vaccine accounts for 88 per cent of all the Covid-19 jabs given in India.

Top headlines: GST hike on textiles on hold; full nod sought for Covishield

Business Standard brings you the top headlines on Friday

Risk-taker gets a booster dose: Meet Adar Poonawalla, CEO, Serum Institute

SII invests 90-95 per cent of its profits every year to build capacities

UK marks Oxford/AstraZeneca Covid-19 vaccine's one-year anniversary

Our fight against COVID in the UK and around the world would not have been possible without the Oxford/AstraZeneca vaccine, said PM Boris Johnson

Vaccine makers bet global demand, boosters will drive growth next year

Domestic demand had fallen after cases began to decline. Omicron surge may reverse the trend

Covid LIVE: Mumbai, Delhi again report sharp rise in daily new cases

2,510 new Covid cases reported in Mumbai on Wednesday, 82% higher than Tuesday, while Delhi reports 86% jump at 923 new infections

DCGI seeks more data from SII over emergency authorisation for Covovax

'The apex drug regulator has also asked the SII to provide details on Matrix component used in the vaccine,' an official source said

Serum Institute on the up as Oxford study backs AstraZ booster for Omicron

Vaxzevria significantly boosts antibodies against the rapidly spreading variant of the coronavirus, shows study

Adar Poonawalla picks up 20% stake in social media platform Wakau

Wakau offers a combination of mobile-first screen experience and short video content in entertainment and fashion domains

Serum Institute CEO hails WHO's approval of Covovax for emergency use

Serum Institute of India (SII) CEO Adar Poonawalla on Friday hailed WHO's approval for emergency use of Covovax vaccine for children "as yet another milestone" in the fight against COVID-19. The World Health Organization (WHO) on Friday listed the Covovax as the ninth COVID-19 vaccine for emergency use with an aim to increase the access to vaccination in lower-income countries. It is produced by the Serum Institute of India under the licence from Novavax. Reacting to the development, Poonawalla tweeted, "This is yet another milestone in our fight against COVID-19, Covovax is now WHO approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration..." He tagged Novavax, WHO, Gavi, the Vaccine Alliance, its CEO Seth Berkley and the Gates Foundation. Earlier this week, Poonawalla had said that SII planned to launch Covovax, a COVID-19 vaccine for children in the next six months. He had stated that Covovax which is under trial would offer ...

Booster shots proven strategy to get antibodies up: Serum's Adar Poonawalla

Says policy makers must decide risk-reward of giving a booster dose; Serum Institute has reached trial phase of vaccine for kids above 3, jab should be ready to launch in six months

No recommendations for Covid booster dose by SEC: Report

The SEC was reviewing the application of the Serum Institute of India (SII) for the booster dose in a meeting that took place on Friday.

Pandemic-hit 2021 sees top Indian cos' valuation rise 68%: Hurun report

The list is led by Mukesh Ambani-led Reliance Industries